nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C19—Memantine—Alzheimer's disease	0.164	0.28	CbGbCtD
Guanfacine—CYP2C9—Donepezil—Alzheimer's disease	0.157	0.268	CbGbCtD
Guanfacine—CYP3A4—Rivastigmine—Alzheimer's disease	0.114	0.195	CbGbCtD
Guanfacine—CYP3A4—Donepezil—Alzheimer's disease	0.0913	0.156	CbGbCtD
Guanfacine—CYP3A4—Galantamine—Alzheimer's disease	0.0588	0.101	CbGbCtD
Guanfacine—Diclofenac—TTR—Alzheimer's disease	0.0052	0.798	CrCbGaD
Guanfacine—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.00125	0.00357	CcSEcCtD
Guanfacine—Affect lability—Rivastigmine—Alzheimer's disease	0.00124	0.00353	CcSEcCtD
Guanfacine—Irritability—Memantine—Alzheimer's disease	0.00123	0.0035	CcSEcCtD
Guanfacine—Asthma—Donepezil—Alzheimer's disease	0.00123	0.00349	CcSEcCtD
Guanfacine—Dysphagia—Donepezil—Alzheimer's disease	0.00123	0.00349	CcSEcCtD
Guanfacine—Visual impairment—Galantamine—Alzheimer's disease	0.00122	0.00348	CcSEcCtD
Guanfacine—Liver function test abnormal—Memantine—Alzheimer's disease	0.00119	0.00339	CcSEcCtD
Guanfacine—Eye disorder—Galantamine—Alzheimer's disease	0.00118	0.00337	CcSEcCtD
Guanfacine—Tinnitus—Galantamine—Alzheimer's disease	0.00118	0.00336	CcSEcCtD
Guanfacine—Orthostatic hypotension—Memantine—Alzheimer's disease	0.00118	0.00335	CcSEcCtD
Guanfacine—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00118	0.00335	CcSEcCtD
Guanfacine—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.00116	0.00332	CcSEcCtD
Guanfacine—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.00115	0.00328	CcSEcCtD
Guanfacine—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.00115	0.00328	CcSEcCtD
Guanfacine—Immune system disorder—Galantamine—Alzheimer's disease	0.00114	0.00326	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.00114	0.00324	CcSEcCtD
Guanfacine—Pollakiuria—Donepezil—Alzheimer's disease	0.00113	0.00323	CcSEcCtD
Guanfacine—Weight increased—Donepezil—Alzheimer's disease	0.00112	0.00318	CcSEcCtD
Guanfacine—Dysphagia—Memantine—Alzheimer's disease	0.00111	0.00317	CcSEcCtD
Guanfacine—Asthma—Memantine—Alzheimer's disease	0.00111	0.00317	CcSEcCtD
Guanfacine—Dysphagia—Rivastigmine—Alzheimer's disease	0.00109	0.0031	CcSEcCtD
Guanfacine—Tension—Galantamine—Alzheimer's disease	0.00108	0.00308	CcSEcCtD
Guanfacine—Dysgeusia—Galantamine—Alzheimer's disease	0.00108	0.00308	CcSEcCtD
Guanfacine—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00108	0.00307	CcSEcCtD
Guanfacine—Myocardial infarction—Donepezil—Alzheimer's disease	0.00107	0.00305	CcSEcCtD
Guanfacine—Nervousness—Galantamine—Alzheimer's disease	0.00107	0.00305	CcSEcCtD
Guanfacine—Conjunctivitis—Donepezil—Alzheimer's disease	0.00106	0.00303	CcSEcCtD
Guanfacine—Muscle spasms—Galantamine—Alzheimer's disease	0.00106	0.00302	CcSEcCtD
Guanfacine—Sweating—Donepezil—Alzheimer's disease	0.00105	0.00299	CcSEcCtD
Guanfacine—Vision blurred—Galantamine—Alzheimer's disease	0.00104	0.00296	CcSEcCtD
Guanfacine—Tremor—Galantamine—Alzheimer's disease	0.00103	0.00294	CcSEcCtD
Guanfacine—Pollakiuria—Memantine—Alzheimer's disease	0.00103	0.00293	CcSEcCtD
Guanfacine—Erectile dysfunction—Memantine—Alzheimer's disease	0.00103	0.00292	CcSEcCtD
Guanfacine—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00102	0.00291	CcSEcCtD
Guanfacine—Weight increased—Memantine—Alzheimer's disease	0.00101	0.00289	CcSEcCtD
Guanfacine—Agitation—Galantamine—Alzheimer's disease	0.00101	0.00289	CcSEcCtD
Guanfacine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.00101	0.00287	CcSEcCtD
Guanfacine—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.001	0.00286	CcSEcCtD
Guanfacine—Bradycardia—Donepezil—Alzheimer's disease	0.000999	0.00285	CcSEcCtD
Guanfacine—Malaise—Galantamine—Alzheimer's disease	0.000994	0.00283	CcSEcCtD
Guanfacine—Weight increased—Rivastigmine—Alzheimer's disease	0.000991	0.00282	CcSEcCtD
Guanfacine—Vertigo—Galantamine—Alzheimer's disease	0.000991	0.00282	CcSEcCtD
Guanfacine—Syncope—Galantamine—Alzheimer's disease	0.000989	0.00282	CcSEcCtD
Guanfacine—Rhinitis—Donepezil—Alzheimer's disease	0.000984	0.0028	CcSEcCtD
Guanfacine—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000979	0.00279	CcSEcCtD
Guanfacine—Hallucination—Donepezil—Alzheimer's disease	0.000977	0.00278	CcSEcCtD
Guanfacine—Palpitations—Galantamine—Alzheimer's disease	0.000974	0.00278	CcSEcCtD
Guanfacine—Myocardial infarction—Memantine—Alzheimer's disease	0.000973	0.00277	CcSEcCtD
Guanfacine—Drowsiness—Rivastigmine—Alzheimer's disease	0.000971	0.00277	CcSEcCtD
Guanfacine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000969	0.00276	CcSEcCtD
Guanfacine—Conjunctivitis—Memantine—Alzheimer's disease	0.000965	0.00275	CcSEcCtD
Guanfacine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000958	0.00273	CcSEcCtD
Guanfacine—Convulsion—Galantamine—Alzheimer's disease	0.000955	0.00272	CcSEcCtD
Guanfacine—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000952	0.00271	CcSEcCtD
Guanfacine—Hypertension—Galantamine—Alzheimer's disease	0.000952	0.00271	CcSEcCtD
Guanfacine—Visual impairment—Donepezil—Alzheimer's disease	0.000946	0.0027	CcSEcCtD
Guanfacine—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000944	0.00269	CcSEcCtD
Guanfacine—Arthralgia—Galantamine—Alzheimer's disease	0.000939	0.00267	CcSEcCtD
Guanfacine—Chest pain—Galantamine—Alzheimer's disease	0.000939	0.00267	CcSEcCtD
Guanfacine—Myalgia—Galantamine—Alzheimer's disease	0.000939	0.00267	CcSEcCtD
Guanfacine—Anxiety—Galantamine—Alzheimer's disease	0.000936	0.00267	CcSEcCtD
Guanfacine—Sweating—Rivastigmine—Alzheimer's disease	0.000931	0.00265	CcSEcCtD
Guanfacine—Discomfort—Galantamine—Alzheimer's disease	0.000928	0.00264	CcSEcCtD
Guanfacine—Dry mouth—Galantamine—Alzheimer's disease	0.000918	0.00262	CcSEcCtD
Guanfacine—Tinnitus—Donepezil—Alzheimer's disease	0.000915	0.00261	CcSEcCtD
Guanfacine—Confusional state—Galantamine—Alzheimer's disease	0.000907	0.00259	CcSEcCtD
Guanfacine—Bradycardia—Memantine—Alzheimer's disease	0.000907	0.00259	CcSEcCtD
Guanfacine—Rhinitis—Memantine—Alzheimer's disease	0.000894	0.00255	CcSEcCtD
Guanfacine—Bradycardia—Rivastigmine—Alzheimer's disease	0.000888	0.00253	CcSEcCtD
Guanfacine—Hallucination—Memantine—Alzheimer's disease	0.000887	0.00253	CcSEcCtD
Guanfacine—Shock—Galantamine—Alzheimer's disease	0.000885	0.00252	CcSEcCtD
Guanfacine—Tachycardia—Galantamine—Alzheimer's disease	0.000878	0.0025	CcSEcCtD
Guanfacine—Rhinitis—Rivastigmine—Alzheimer's disease	0.000874	0.00249	CcSEcCtD
Guanfacine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00087	0.00248	CcSEcCtD
Guanfacine—Hallucination—Rivastigmine—Alzheimer's disease	0.000868	0.00247	CcSEcCtD
Guanfacine—Alopecia—Donepezil—Alzheimer's disease	0.000867	0.00247	CcSEcCtD
Guanfacine—Visual impairment—Memantine—Alzheimer's disease	0.000859	0.00245	CcSEcCtD
Guanfacine—Hypotension—Galantamine—Alzheimer's disease	0.000841	0.0024	CcSEcCtD
Guanfacine—Visual impairment—Rivastigmine—Alzheimer's disease	0.00084	0.00239	CcSEcCtD
Guanfacine—Tension—Donepezil—Alzheimer's disease	0.000839	0.00239	CcSEcCtD
Guanfacine—Diclofenac—PTGS1—Alzheimer's disease	0.000838	0.129	CrCbGaD
Guanfacine—Dysgeusia—Donepezil—Alzheimer's disease	0.000837	0.00238	CcSEcCtD
Guanfacine—Eye disorder—Memantine—Alzheimer's disease	0.000833	0.00237	CcSEcCtD
Guanfacine—Tinnitus—Memantine—Alzheimer's disease	0.000831	0.00237	CcSEcCtD
Guanfacine—Nervousness—Donepezil—Alzheimer's disease	0.00083	0.00236	CcSEcCtD
Guanfacine—Muscle spasms—Donepezil—Alzheimer's disease	0.000822	0.00234	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00082	0.00234	CcSEcCtD
Guanfacine—Eye disorder—Rivastigmine—Alzheimer's disease	0.000815	0.00232	CcSEcCtD
Guanfacine—Insomnia—Galantamine—Alzheimer's disease	0.000814	0.00232	CcSEcCtD
Guanfacine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000813	0.00232	CcSEcCtD
Guanfacine—Paraesthesia—Galantamine—Alzheimer's disease	0.000808	0.0023	CcSEcCtD
Guanfacine—Vision blurred—Donepezil—Alzheimer's disease	0.000805	0.00229	CcSEcCtD
Guanfacine—Immune system disorder—Memantine—Alzheimer's disease	0.000805	0.00229	CcSEcCtD
Guanfacine—Tremor—Donepezil—Alzheimer's disease	0.000801	0.00228	CcSEcCtD
Guanfacine—Somnolence—Galantamine—Alzheimer's disease	0.0008	0.00228	CcSEcCtD
Guanfacine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000793	0.00226	CcSEcCtD
Guanfacine—Dyspepsia—Galantamine—Alzheimer's disease	0.000792	0.00226	CcSEcCtD
Guanfacine—Alopecia—Memantine—Alzheimer's disease	0.000788	0.00224	CcSEcCtD
Guanfacine—Agitation—Donepezil—Alzheimer's disease	0.000785	0.00224	CcSEcCtD
Guanfacine—Decreased appetite—Galantamine—Alzheimer's disease	0.000782	0.00223	CcSEcCtD
Guanfacine—Fatigue—Galantamine—Alzheimer's disease	0.000776	0.00221	CcSEcCtD
Guanfacine—Malaise—Donepezil—Alzheimer's disease	0.000771	0.0022	CcSEcCtD
Guanfacine—Alopecia—Rivastigmine—Alzheimer's disease	0.000771	0.0022	CcSEcCtD
Guanfacine—Constipation—Galantamine—Alzheimer's disease	0.00077	0.00219	CcSEcCtD
Guanfacine—Vertigo—Donepezil—Alzheimer's disease	0.000768	0.00219	CcSEcCtD
Guanfacine—Syncope—Donepezil—Alzheimer's disease	0.000766	0.00218	CcSEcCtD
Guanfacine—Tension—Memantine—Alzheimer's disease	0.000761	0.00217	CcSEcCtD
Guanfacine—Dysgeusia—Memantine—Alzheimer's disease	0.00076	0.00216	CcSEcCtD
Guanfacine—Nervousness—Memantine—Alzheimer's disease	0.000754	0.00215	CcSEcCtD
Guanfacine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000751	0.00214	CcSEcCtD
Guanfacine—Tension—Rivastigmine—Alzheimer's disease	0.000745	0.00212	CcSEcCtD
Guanfacine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000743	0.00212	CcSEcCtD
Guanfacine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000742	0.00211	CcSEcCtD
Guanfacine—Convulsion—Donepezil—Alzheimer's disease	0.00074	0.00211	CcSEcCtD
Guanfacine—Hypertension—Donepezil—Alzheimer's disease	0.000738	0.0021	CcSEcCtD
Guanfacine—Nervousness—Rivastigmine—Alzheimer's disease	0.000737	0.0021	CcSEcCtD
Guanfacine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000736	0.0021	CcSEcCtD
Guanfacine—Vision blurred—Memantine—Alzheimer's disease	0.000731	0.00208	CcSEcCtD
Guanfacine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00073	0.00208	CcSEcCtD
Guanfacine—Arthralgia—Donepezil—Alzheimer's disease	0.000728	0.00207	CcSEcCtD
Guanfacine—Myalgia—Donepezil—Alzheimer's disease	0.000728	0.00207	CcSEcCtD
Guanfacine—Chest pain—Donepezil—Alzheimer's disease	0.000728	0.00207	CcSEcCtD
Guanfacine—Tremor—Memantine—Alzheimer's disease	0.000727	0.00207	CcSEcCtD
Guanfacine—Anxiety—Donepezil—Alzheimer's disease	0.000725	0.00207	CcSEcCtD
Guanfacine—Ill-defined disorder—Memantine—Alzheimer's disease	0.00072	0.00205	CcSEcCtD
Guanfacine—Discomfort—Donepezil—Alzheimer's disease	0.000719	0.00205	CcSEcCtD
Guanfacine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000715	0.00204	CcSEcCtD
Guanfacine—Agitation—Memantine—Alzheimer's disease	0.000713	0.00203	CcSEcCtD
Guanfacine—Dry mouth—Donepezil—Alzheimer's disease	0.000712	0.00203	CcSEcCtD
Guanfacine—Abdominal pain—Galantamine—Alzheimer's disease	0.000711	0.00203	CcSEcCtD
Guanfacine—Tremor—Rivastigmine—Alzheimer's disease	0.000711	0.00203	CcSEcCtD
Guanfacine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000704	0.00201	CcSEcCtD
Guanfacine—Confusional state—Donepezil—Alzheimer's disease	0.000703	0.002	CcSEcCtD
Guanfacine—Malaise—Memantine—Alzheimer's disease	0.0007	0.00199	CcSEcCtD
Guanfacine—Agitation—Rivastigmine—Alzheimer's disease	0.000698	0.00199	CcSEcCtD
Guanfacine—Oedema—Donepezil—Alzheimer's disease	0.000697	0.00199	CcSEcCtD
Guanfacine—Vertigo—Memantine—Alzheimer's disease	0.000697	0.00199	CcSEcCtD
Guanfacine—Syncope—Memantine—Alzheimer's disease	0.000696	0.00198	CcSEcCtD
Guanfacine—Shock—Donepezil—Alzheimer's disease	0.000686	0.00195	CcSEcCtD
Guanfacine—Palpitations—Memantine—Alzheimer's disease	0.000686	0.00195	CcSEcCtD
Guanfacine—Malaise—Rivastigmine—Alzheimer's disease	0.000685	0.00195	CcSEcCtD
Guanfacine—Vertigo—Rivastigmine—Alzheimer's disease	0.000682	0.00194	CcSEcCtD
Guanfacine—Loss of consciousness—Memantine—Alzheimer's disease	0.000682	0.00194	CcSEcCtD
Guanfacine—Syncope—Rivastigmine—Alzheimer's disease	0.000681	0.00194	CcSEcCtD
Guanfacine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000674	0.00192	CcSEcCtD
Guanfacine—Convulsion—Memantine—Alzheimer's disease	0.000672	0.00192	CcSEcCtD
Guanfacine—Palpitations—Rivastigmine—Alzheimer's disease	0.000671	0.00191	CcSEcCtD
Guanfacine—Hypertension—Memantine—Alzheimer's disease	0.00067	0.00191	CcSEcCtD
Guanfacine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000667	0.0019	CcSEcCtD
Guanfacine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000663	0.00189	CcSEcCtD
Guanfacine—Arthralgia—Memantine—Alzheimer's disease	0.000661	0.00188	CcSEcCtD
Guanfacine—Chest pain—Memantine—Alzheimer's disease	0.000661	0.00188	CcSEcCtD
Guanfacine—Myalgia—Memantine—Alzheimer's disease	0.000661	0.00188	CcSEcCtD
Guanfacine—Anxiety—Memantine—Alzheimer's disease	0.000658	0.00188	CcSEcCtD
Guanfacine—Convulsion—Rivastigmine—Alzheimer's disease	0.000658	0.00187	CcSEcCtD
Guanfacine—Hypertension—Rivastigmine—Alzheimer's disease	0.000655	0.00187	CcSEcCtD
Guanfacine—Discomfort—Memantine—Alzheimer's disease	0.000653	0.00186	CcSEcCtD
Guanfacine—Hypotension—Donepezil—Alzheimer's disease	0.000652	0.00186	CcSEcCtD
Guanfacine—Myalgia—Rivastigmine—Alzheimer's disease	0.000646	0.00184	CcSEcCtD
Guanfacine—Arthralgia—Rivastigmine—Alzheimer's disease	0.000646	0.00184	CcSEcCtD
Guanfacine—Chest pain—Rivastigmine—Alzheimer's disease	0.000646	0.00184	CcSEcCtD
Guanfacine—Dry mouth—Memantine—Alzheimer's disease	0.000646	0.00184	CcSEcCtD
Guanfacine—Asthenia—Galantamine—Alzheimer's disease	0.000646	0.00184	CcSEcCtD
Guanfacine—Anxiety—Rivastigmine—Alzheimer's disease	0.000644	0.00183	CcSEcCtD
Guanfacine—Confusional state—Memantine—Alzheimer's disease	0.000639	0.00182	CcSEcCtD
Guanfacine—Discomfort—Rivastigmine—Alzheimer's disease	0.000639	0.00182	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000635	0.00181	CcSEcCtD
Guanfacine—Oedema—Memantine—Alzheimer's disease	0.000633	0.0018	CcSEcCtD
Guanfacine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000632	0.0018	CcSEcCtD
Guanfacine—Insomnia—Donepezil—Alzheimer's disease	0.000631	0.0018	CcSEcCtD
Guanfacine—Paraesthesia—Donepezil—Alzheimer's disease	0.000626	0.00178	CcSEcCtD
Guanfacine—Confusional state—Rivastigmine—Alzheimer's disease	0.000625	0.00178	CcSEcCtD
Guanfacine—Shock—Memantine—Alzheimer's disease	0.000623	0.00177	CcSEcCtD
Guanfacine—Dyspnoea—Donepezil—Alzheimer's disease	0.000622	0.00177	CcSEcCtD
Guanfacine—Somnolence—Donepezil—Alzheimer's disease	0.00062	0.00177	CcSEcCtD
Guanfacine—Oedema—Rivastigmine—Alzheimer's disease	0.00062	0.00176	CcSEcCtD
Guanfacine—Tachycardia—Memantine—Alzheimer's disease	0.000618	0.00176	CcSEcCtD
Guanfacine—Diarrhoea—Galantamine—Alzheimer's disease	0.000616	0.00175	CcSEcCtD
Guanfacine—Dyspepsia—Donepezil—Alzheimer's disease	0.000614	0.00175	CcSEcCtD
Guanfacine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000612	0.00174	CcSEcCtD
Guanfacine—Shock—Rivastigmine—Alzheimer's disease	0.00061	0.00174	CcSEcCtD
Guanfacine—Decreased appetite—Donepezil—Alzheimer's disease	0.000606	0.00173	CcSEcCtD
Guanfacine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000605	0.00172	CcSEcCtD
Guanfacine—Fatigue—Donepezil—Alzheimer's disease	0.000601	0.00171	CcSEcCtD
Guanfacine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000599	0.00171	CcSEcCtD
Guanfacine—Constipation—Donepezil—Alzheimer's disease	0.000596	0.0017	CcSEcCtD
Guanfacine—Dizziness—Galantamine—Alzheimer's disease	0.000595	0.0017	CcSEcCtD
Guanfacine—Hypotension—Memantine—Alzheimer's disease	0.000592	0.00169	CcSEcCtD
Guanfacine—Hypotension—Rivastigmine—Alzheimer's disease	0.000579	0.00165	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000577	0.00164	CcSEcCtD
Guanfacine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000575	0.00164	CcSEcCtD
Guanfacine—Insomnia—Memantine—Alzheimer's disease	0.000573	0.00163	CcSEcCtD
Guanfacine—Vomiting—Galantamine—Alzheimer's disease	0.000572	0.00163	CcSEcCtD
Guanfacine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00057	0.00162	CcSEcCtD
Guanfacine—Paraesthesia—Memantine—Alzheimer's disease	0.000569	0.00162	CcSEcCtD
Guanfacine—Rash—Galantamine—Alzheimer's disease	0.000567	0.00162	CcSEcCtD
Guanfacine—Dermatitis—Galantamine—Alzheimer's disease	0.000567	0.00162	CcSEcCtD
Guanfacine—Dyspnoea—Memantine—Alzheimer's disease	0.000565	0.00161	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000564	0.00161	CcSEcCtD
Guanfacine—Headache—Galantamine—Alzheimer's disease	0.000564	0.00161	CcSEcCtD
Guanfacine—Somnolence—Memantine—Alzheimer's disease	0.000563	0.0016	CcSEcCtD
Guanfacine—Insomnia—Rivastigmine—Alzheimer's disease	0.00056	0.0016	CcSEcCtD
Guanfacine—Dyspepsia—Memantine—Alzheimer's disease	0.000557	0.00159	CcSEcCtD
Guanfacine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000556	0.00158	CcSEcCtD
Guanfacine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000552	0.00157	CcSEcCtD
Guanfacine—Abdominal pain—Donepezil—Alzheimer's disease	0.000551	0.00157	CcSEcCtD
Guanfacine—Somnolence—Rivastigmine—Alzheimer's disease	0.000551	0.00157	CcSEcCtD
Guanfacine—Decreased appetite—Memantine—Alzheimer's disease	0.00055	0.00157	CcSEcCtD
Guanfacine—Fatigue—Memantine—Alzheimer's disease	0.000546	0.00156	CcSEcCtD
Guanfacine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000545	0.00155	CcSEcCtD
Guanfacine—Constipation—Memantine—Alzheimer's disease	0.000542	0.00154	CcSEcCtD
Guanfacine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000539	0.00153	CcSEcCtD
Guanfacine—Nausea—Galantamine—Alzheimer's disease	0.000535	0.00152	CcSEcCtD
Guanfacine—Fatigue—Rivastigmine—Alzheimer's disease	0.000534	0.00152	CcSEcCtD
Guanfacine—Constipation—Rivastigmine—Alzheimer's disease	0.00053	0.00151	CcSEcCtD
Guanfacine—Feeling abnormal—Memantine—Alzheimer's disease	0.000522	0.00149	CcSEcCtD
Guanfacine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000518	0.00148	CcSEcCtD
Guanfacine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000514	0.00146	CcSEcCtD
Guanfacine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000511	0.00145	CcSEcCtD
Guanfacine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000507	0.00144	CcSEcCtD
Guanfacine—Abdominal pain—Memantine—Alzheimer's disease	0.000501	0.00143	CcSEcCtD
Guanfacine—Asthenia—Donepezil—Alzheimer's disease	0.0005	0.00143	CcSEcCtD
Guanfacine—Pruritus—Donepezil—Alzheimer's disease	0.000493	0.00141	CcSEcCtD
Guanfacine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00049	0.0014	CcSEcCtD
Guanfacine—Diclofenac—PTGS2—Alzheimer's disease	0.000479	0.0735	CrCbGaD
Guanfacine—Diarrhoea—Donepezil—Alzheimer's disease	0.000477	0.00136	CcSEcCtD
Guanfacine—Hypersensitivity—Memantine—Alzheimer's disease	0.000467	0.00133	CcSEcCtD
Guanfacine—Dizziness—Donepezil—Alzheimer's disease	0.000461	0.00131	CcSEcCtD
Guanfacine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000456	0.0013	CcSEcCtD
Guanfacine—Asthenia—Memantine—Alzheimer's disease	0.000454	0.00129	CcSEcCtD
Guanfacine—Pruritus—Memantine—Alzheimer's disease	0.000448	0.00128	CcSEcCtD
Guanfacine—Asthenia—Rivastigmine—Alzheimer's disease	0.000444	0.00127	CcSEcCtD
Guanfacine—Vomiting—Donepezil—Alzheimer's disease	0.000443	0.00126	CcSEcCtD
Guanfacine—Rash—Donepezil—Alzheimer's disease	0.00044	0.00125	CcSEcCtD
Guanfacine—Dermatitis—Donepezil—Alzheimer's disease	0.000439	0.00125	CcSEcCtD
Guanfacine—Pruritus—Rivastigmine—Alzheimer's disease	0.000438	0.00125	CcSEcCtD
Guanfacine—Headache—Donepezil—Alzheimer's disease	0.000437	0.00124	CcSEcCtD
Guanfacine—Diarrhoea—Memantine—Alzheimer's disease	0.000433	0.00123	CcSEcCtD
Guanfacine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000424	0.00121	CcSEcCtD
Guanfacine—Dizziness—Memantine—Alzheimer's disease	0.000419	0.00119	CcSEcCtD
Guanfacine—Nausea—Donepezil—Alzheimer's disease	0.000414	0.00118	CcSEcCtD
Guanfacine—Dizziness—Rivastigmine—Alzheimer's disease	0.00041	0.00117	CcSEcCtD
Guanfacine—Vomiting—Memantine—Alzheimer's disease	0.000403	0.00115	CcSEcCtD
Guanfacine—Rash—Memantine—Alzheimer's disease	0.000399	0.00114	CcSEcCtD
Guanfacine—Dermatitis—Memantine—Alzheimer's disease	0.000399	0.00114	CcSEcCtD
Guanfacine—Headache—Memantine—Alzheimer's disease	0.000397	0.00113	CcSEcCtD
Guanfacine—Vomiting—Rivastigmine—Alzheimer's disease	0.000394	0.00112	CcSEcCtD
Guanfacine—Rash—Rivastigmine—Alzheimer's disease	0.000391	0.00111	CcSEcCtD
Guanfacine—Dermatitis—Rivastigmine—Alzheimer's disease	0.00039	0.00111	CcSEcCtD
Guanfacine—Headache—Rivastigmine—Alzheimer's disease	0.000388	0.00111	CcSEcCtD
Guanfacine—Nausea—Memantine—Alzheimer's disease	0.000376	0.00107	CcSEcCtD
Guanfacine—Nausea—Rivastigmine—Alzheimer's disease	0.000368	0.00105	CcSEcCtD
Guanfacine—ADRA2A—Metabolism—GAPDH—Alzheimer's disease	2.81e-05	0.00049	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—CCR5—Alzheimer's disease	2.8e-05	0.000488	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APH1A—Alzheimer's disease	2.78e-05	0.000484	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PLCB1—Alzheimer's disease	2.75e-05	0.000479	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.74e-05	0.000477	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.73e-05	0.000476	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—A2M—Alzheimer's disease	2.72e-05	0.000474	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NCSTN—Alzheimer's disease	2.71e-05	0.000472	CbGpPWpGaD
Guanfacine—ADRA2B—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	2.69e-05	0.000469	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PRKCG—Alzheimer's disease	2.68e-05	0.000467	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NPY—Alzheimer's disease	2.67e-05	0.000465	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.66e-05	0.000464	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IAPP—Alzheimer's disease	2.65e-05	0.000462	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LRP1—Alzheimer's disease	2.64e-05	0.00046	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.58e-05	0.00045	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GFAP—Alzheimer's disease	2.58e-05	0.000449	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GAL—Alzheimer's disease	2.58e-05	0.000449	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CRH—Alzheimer's disease	2.58e-05	0.000449	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CCR5—Alzheimer's disease	2.54e-05	0.000443	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—IGF1—Alzheimer's disease	2.52e-05	0.00044	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.5e-05	0.000436	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—HTR2A—Alzheimer's disease	2.49e-05	0.000433	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NPS—Alzheimer's disease	2.44e-05	0.000425	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PPP3CA—Alzheimer's disease	2.43e-05	0.000423	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—F2—Alzheimer's disease	2.4e-05	0.000418	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PTK2B—Alzheimer's disease	2.39e-05	0.000417	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.37e-05	0.000413	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ACHE—Alzheimer's disease	2.36e-05	0.000412	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.35e-05	0.00041	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.35e-05	0.00041	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—INPP5D—Alzheimer's disease	2.34e-05	0.000407	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SST—Alzheimer's disease	2.33e-05	0.000406	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—GAB2—Alzheimer's disease	2.33e-05	0.000406	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NTRK2—Alzheimer's disease	2.33e-05	0.000406	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CALM1—Alzheimer's disease	2.32e-05	0.000404	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—GSK3A—Alzheimer's disease	2.31e-05	0.000402	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—NOS3—Alzheimer's disease	2.29e-05	0.000399	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—A2M—Alzheimer's disease	2.27e-05	0.000396	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APP—Alzheimer's disease	2.27e-05	0.000396	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	2.26e-05	0.000394	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PRKCG—Alzheimer's disease	2.24e-05	0.00039	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTGS1—Alzheimer's disease	2.22e-05	0.000386	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ENO1—Alzheimer's disease	2.22e-05	0.000386	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PSEN2—Alzheimer's disease	2.2e-05	0.000384	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—F2—Alzheimer's disease	2.18e-05	0.00038	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—VEGFA—Alzheimer's disease	2.17e-05	0.000379	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CYP2D6—Alzheimer's disease	2.17e-05	0.000379	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	2.17e-05	0.000378	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CHAT—Alzheimer's disease	2.16e-05	0.000376	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—TPI1—Alzheimer's disease	2.16e-05	0.000376	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.14e-05	0.000374	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PLCB1—Alzheimer's disease	2.14e-05	0.000373	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CCR5—Alzheimer's disease	2.12e-05	0.00037	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	2.09e-05	0.000364	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.08e-05	0.000362	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—MAOB—Alzheimer's disease	2.07e-05	0.000361	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—BCHE—Alzheimer's disease	2.06e-05	0.000359	CbGpPWpGaD
Guanfacine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	2.04e-05	0.000356	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PRKCG—Alzheimer's disease	2.03e-05	0.000354	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NPY—Alzheimer's disease	2.03e-05	0.000353	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ND1—Alzheimer's disease	2.02e-05	0.000351	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IAPP—Alzheimer's disease	2.01e-05	0.000351	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NGFR—Alzheimer's disease	2e-05	0.000348	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—TGFB1—Alzheimer's disease	2e-05	0.000348	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	1.99e-05	0.000347	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CREB1—Alzheimer's disease	1.99e-05	0.000346	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.97e-05	0.000343	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.97e-05	0.000343	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.97e-05	0.000343	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CRH—Alzheimer's disease	1.95e-05	0.000341	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.95e-05	0.00034	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ADAM10—Alzheimer's disease	1.95e-05	0.00034	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PLCB1—Alzheimer's disease	1.94e-05	0.000339	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CCL2—Alzheimer's disease	1.94e-05	0.000339	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CCR5—Alzheimer's disease	1.93e-05	0.000336	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—A2M—Alzheimer's disease	1.93e-05	0.000336	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.89e-05	0.000329	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—HTR2A—Alzheimer's disease	1.89e-05	0.000329	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ABCA1—Alzheimer's disease	1.88e-05	0.000328	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NPS—Alzheimer's disease	1.85e-05	0.000323	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—S100B—Alzheimer's disease	1.85e-05	0.000322	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PPP3CA—Alzheimer's disease	1.84e-05	0.000321	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—F2—Alzheimer's disease	1.82e-05	0.000317	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1.82e-05	0.000317	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PTK2B—Alzheimer's disease	1.82e-05	0.000317	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.8e-05	0.000313	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.78e-05	0.00031	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GAB2—Alzheimer's disease	1.77e-05	0.000308	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SST—Alzheimer's disease	1.77e-05	0.000308	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NTRK2—Alzheimer's disease	1.77e-05	0.000308	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CALM1—Alzheimer's disease	1.76e-05	0.000307	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IGF2—Alzheimer's disease	1.76e-05	0.000306	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—A2M—Alzheimer's disease	1.76e-05	0.000306	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GSK3A—Alzheimer's disease	1.75e-05	0.000305	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APP—Alzheimer's disease	1.72e-05	0.0003	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.72e-05	0.000299	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IGF1R—Alzheimer's disease	1.7e-05	0.000296	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ACHE—Alzheimer's disease	1.67e-05	0.000292	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	1.66e-05	0.000289	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—F2—Alzheimer's disease	1.65e-05	0.000288	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—VEGFA—Alzheimer's disease	1.65e-05	0.000287	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—TP53—Alzheimer's disease	1.64e-05	0.000286	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—LPL—Alzheimer's disease	1.63e-05	0.000284	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PLCB1—Alzheimer's disease	1.62e-05	0.000283	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PPARGC1A—Alzheimer's disease	1.62e-05	0.000283	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—HMOX1—Alzheimer's disease	1.62e-05	0.000282	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MEF2C—Alzheimer's disease	1.61e-05	0.000281	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PRKCG—Alzheimer's disease	1.58e-05	0.000276	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ENO1—Alzheimer's disease	1.57e-05	0.000274	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	1.57e-05	0.000274	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.57e-05	0.000273	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NGF—Alzheimer's disease	1.54e-05	0.000269	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	1.54e-05	0.000268	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ACHE—Alzheimer's disease	1.53e-05	0.000266	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NGFR—Alzheimer's disease	1.52e-05	0.000264	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—TGFB1—Alzheimer's disease	1.51e-05	0.000264	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	1.51e-05	0.000263	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CREB1—Alzheimer's disease	1.51e-05	0.000263	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCR5—Alzheimer's disease	1.5e-05	0.000262	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ADAM10—Alzheimer's disease	1.48e-05	0.000258	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—LPL—Alzheimer's disease	1.48e-05	0.000258	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CCL2—Alzheimer's disease	1.47e-05	0.000257	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HTR2A—Alzheimer's disease	1.47e-05	0.000256	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—BCHE—Alzheimer's disease	1.46e-05	0.000254	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	1.43e-05	0.000249	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ENO1—Alzheimer's disease	1.43e-05	0.000249	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	1.4e-05	0.000245	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—S100B—Alzheimer's disease	1.4e-05	0.000244	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—AKT1—Alzheimer's disease	1.39e-05	0.000242	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	1.38e-05	0.00024	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CALM1—Alzheimer's disease	1.37e-05	0.000239	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APOE—Alzheimer's disease	1.37e-05	0.000238	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—LEP—Alzheimer's disease	1.37e-05	0.000238	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CAV1—Alzheimer's disease	1.35e-05	0.000236	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.35e-05	0.000235	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	1.33e-05	0.000233	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IGF2—Alzheimer's disease	1.33e-05	0.000232	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—MTHFR—Alzheimer's disease	1.33e-05	0.000232	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—BCHE—Alzheimer's disease	1.33e-05	0.000232	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ESR1—Alzheimer's disease	1.3e-05	0.000227	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.3e-05	0.000226	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.3e-05	0.000226	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IGF1R—Alzheimer's disease	1.29e-05	0.000225	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—F2—Alzheimer's disease	1.29e-05	0.000224	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NOTCH1—Alzheimer's disease	1.26e-05	0.00022	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	1.26e-05	0.000219	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—TP53—Alzheimer's disease	1.25e-05	0.000217	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.25e-05	0.000217	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CALM1—Alzheimer's disease	1.24e-05	0.000217	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—APOE—Alzheimer's disease	1.24e-05	0.000216	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	1.24e-05	0.000215	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.23e-05	0.000215	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CAV1—Alzheimer's disease	1.23e-05	0.000214	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	1.22e-05	0.000213	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	1.22e-05	0.000212	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	1.2e-05	0.000209	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.2e-05	0.000209	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—GSK3B—Alzheimer's disease	1.18e-05	0.000206	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CREB1—Alzheimer's disease	1.17e-05	0.000204	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	1.17e-05	0.000204	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—INS—Alzheimer's disease	1.17e-05	0.000203	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.16e-05	0.000202	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	1.15e-05	0.0002	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCL2—Alzheimer's disease	1.15e-05	0.0002	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	1.14e-05	0.0002	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	1.14e-05	0.000198	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IGF1—Alzheimer's disease	1.13e-05	0.000197	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	1.11e-05	0.000194	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PPARG—Alzheimer's disease	1.08e-05	0.000188	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—INS—Alzheimer's disease	1.06e-05	0.000184	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	1.05e-05	0.000183	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	1.05e-05	0.000183	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—LPL—Alzheimer's disease	1.05e-05	0.000182	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	1.04e-05	0.000182	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	1.04e-05	0.000181	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	1.04e-05	0.000181	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	1.04e-05	0.000181	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	1.03e-05	0.000179	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NOS3—Alzheimer's disease	1.02e-05	0.000178	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.01e-05	0.000176	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	9.95e-06	0.000173	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	9.89e-06	0.000172	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	9.77e-06	0.00017	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	9.56e-06	0.000167	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—LPL—Alzheimer's disease	9.55e-06	0.000166	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	9.44e-06	0.000164	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	9.44e-06	0.000164	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	9.43e-06	0.000164	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—NOS3—Alzheimer's disease	9.28e-06	0.000162	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	9.25e-06	0.000161	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	8.97e-06	0.000156	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	8.9e-06	0.000155	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	8.85e-06	0.000154	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	8.81e-06	0.000154	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOE—Alzheimer's disease	8.78e-06	0.000153	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	8.77e-06	0.000153	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	8.76e-06	0.000153	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	8.71e-06	0.000152	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	8.7e-06	0.000152	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	8.68e-06	0.000151	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	8.63e-06	0.00015	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	8.6e-06	0.00015	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	8.56e-06	0.000149	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	8.49e-06	0.000148	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	8.28e-06	0.000144	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	8.03e-06	0.00014	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	8.02e-06	0.00014	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOE—Alzheimer's disease	8e-06	0.000139	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	7.98e-06	0.000139	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	7.96e-06	0.000139	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	7.93e-06	0.000138	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	7.76e-06	0.000135	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	7.64e-06	0.000133	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—INS—Alzheimer's disease	7.5e-06	0.000131	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	7.37e-06	0.000128	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	6.97e-06	0.000121	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	6.92e-06	0.000121	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	6.88e-06	0.00012	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—INS—Alzheimer's disease	6.84e-06	0.000119	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	6.76e-06	0.000118	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	6.65e-06	0.000116	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	6.59e-06	0.000115	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	6.58e-06	0.000115	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	6.55e-06	0.000114	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LPL—Alzheimer's disease	6.3e-06	0.00011	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	6.06e-06	0.000106	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	6.04e-06	0.000105	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	6.01e-06	0.000105	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	6e-06	0.000104	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	5.67e-06	9.88e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	5.59e-06	9.74e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	5.57e-06	9.7e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	5.48e-06	9.56e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	5.3e-06	9.23e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOE—Alzheimer's disease	5.28e-06	9.2e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	5.23e-06	9.11e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	5.13e-06	8.94e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	5.1e-06	8.88e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	4.7e-06	8.19e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	4.6e-06	8.01e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—INS—Alzheimer's disease	4.51e-06	7.86e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	4.27e-06	7.44e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	4.22e-06	7.36e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.95e-06	6.89e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	3.87e-06	6.74e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	3.62e-06	6.3e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	3.57e-06	6.22e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	3.02e-06	5.27e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	2.76e-06	4.8e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.82e-06	3.17e-05	CbGpPWpGaD
